000442800 001__ 442800
000442800 005__ 20250729150637.0
000442800 0247_ $$2doi$$a10.1016/j.ejmech.2019.111825
000442800 0247_ $$2ISSN$$a0009-4374
000442800 0247_ $$2ISSN$$a0223-5234
000442800 0247_ $$2ISSN$$a1768-3254
000442800 0247_ $$2pmid$$apmid:31740053
000442800 0247_ $$2WOS$$aWOS:000503099900056
000442800 0247_ $$2openalex$$aopenalex:W2982365748
000442800 037__ $$aPUBDB-2020-03220
000442800 041__ $$aEnglish
000442800 082__ $$a610
000442800 1001_ $$aZakšauskas, Audrius$$b0
000442800 245__ $$aHalogenated and di-substituted benzenesulfonamides as selective inhibitors of carbonic anhydrase isoforms
000442800 260__ $$aAmsterdam [u.a.]$$bElsevier10887$$c2020
000442800 264_1 $$2Crossref$$3print$$bElsevier BV$$c2020-01-01
000442800 3367_ $$2DRIVER$$aarticle
000442800 3367_ $$2DataCite$$aOutput Types/Journal article
000442800 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1599476424_12371
000442800 3367_ $$2BibTeX$$aARTICLE
000442800 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000442800 3367_ $$00$$2EndNote$$aJournal Article
000442800 520__ $$aBy applying an approach of a “ring with two tails”, a series of novel inhibitors possessing high-affinity and significant selectivity towards selected carbonic anhydrase (CA) isoforms has been designed. The “ring” consists of 2-chloro/bromo-benzenesulfonamide, where the sulfonamide group is as an anchor coordinating the Zn(II) in the active site of CAs, and halogen atom orients the ring affecting the affinity and selectivity. First “tail” is a substituent containing carbonyl, carboxyl, hydroxyl, ether groups or hydrophilic amide linkage. The second “tail” contains aryl- or alkyl-substituents attached through a sulfanyl or sulfonyl group. Both “tails” are connected to the benzene ring and play a crucial role in selectivity. Varying the substituents, we designed compounds selective for CA VII, CA IX, CA XII, or CA XIV.Since due to binding-linked protonation reactions the binding-ready fractions of the compound and protein are much lower than one, the “intrinsic” affinities were calculated that should be used to study correlations between crystal structures and the thermodynamics of binding for rational drug design. The “intrinsic” affinities together with the intrinsic enthalpies and entropies of binding together with co-crystal structures were used demonstrate structural factors determining major contributions for compound affinity and selectivity.
000442800 536__ $$0G:(DE-HGF)POF3-6G3$$a6G3 - PETRA III (POF3-622)$$cPOF3-622$$fPOF III$$x0
000442800 542__ $$2Crossref$$i2020-01-01$$uhttps://www.elsevier.com/tdm/userlicense/1.0/
000442800 588__ $$aDataset connected to CrossRef
000442800 693__ $$0EXP:(DE-H253)P-P14-20150101$$1EXP:(DE-H253)PETRAIII-20150101$$6EXP:(DE-H253)P-P14-20150101$$aPETRA III$$fPETRA Beamline P14$$x0
000442800 7001_ $$aČapkauskaitė, Edita$$b1
000442800 7001_ $$aJezepčikas, Linas$$b2
000442800 7001_ $$aLinkuvienė, Vaida$$b3
000442800 7001_ $$aPaketurytė, Vaida$$b4
000442800 7001_ $$aSmirnov, Alexey$$b5
000442800 7001_ $$aLeitans, Janis$$b6
000442800 7001_ $$aKazaks, Andris$$b7
000442800 7001_ $$aDvinskis, Elviss$$b8
000442800 7001_ $$aManakova, Elena$$b9
000442800 7001_ $$aGražulis, Saulius$$b10
000442800 7001_ $$aTars, Kaspars$$b11
000442800 7001_ $$00000-0002-6178-6276$$aMatulis, Daumantas$$b12$$eCorresponding author
000442800 77318 $$2Crossref$$3journal-article$$a10.1016/j.ejmech.2019.111825$$b : Elsevier BV, 2020-01-01$$p111825$$tEuropean Journal of Medicinal Chemistry$$v185$$x0223-5234$$y2020
000442800 773__ $$0PERI:(DE-600)2005170-0$$a10.1016/j.ejmech.2019.111825$$gVol. 185, p. 111825 -$$p111825$$tEuropean journal of medicinal chemistry$$v185$$x0223-5234$$y2020
000442800 8564_ $$uhttps://www.sciencedirect.com/science/article/pii/S0223523419309778?via%3Dihub
000442800 8564_ $$uhttps://bib-pubdb1.desy.de/record/442800/files/Halogenated%20and%20di-substituted%20benzenesulfonamides%20as%20selective%20inhibitors%20of%20carbonic%20anhydrase%20isoforms.pdf$$yRestricted
000442800 8564_ $$uhttps://bib-pubdb1.desy.de/record/442800/files/Halogenated%20and%20di-substituted%20benzenesulfonamides%20as%20selective%20inhibitors%20of%20carbonic%20anhydrase%20isoforms.gif?subformat=icon$$xicon$$yRestricted
000442800 8564_ $$uhttps://bib-pubdb1.desy.de/record/442800/files/Halogenated%20and%20di-substituted%20benzenesulfonamides%20as%20selective%20inhibitors%20of%20carbonic%20anhydrase%20isoforms.jpg?subformat=icon-1440$$xicon-1440$$yRestricted
000442800 8564_ $$uhttps://bib-pubdb1.desy.de/record/442800/files/Halogenated%20and%20di-substituted%20benzenesulfonamides%20as%20selective%20inhibitors%20of%20carbonic%20anhydrase%20isoforms.jpg?subformat=icon-180$$xicon-180$$yRestricted
000442800 8564_ $$uhttps://bib-pubdb1.desy.de/record/442800/files/Halogenated%20and%20di-substituted%20benzenesulfonamides%20as%20selective%20inhibitors%20of%20carbonic%20anhydrase%20isoforms.jpg?subformat=icon-640$$xicon-640$$yRestricted
000442800 8564_ $$uhttps://bib-pubdb1.desy.de/record/442800/files/Halogenated%20and%20di-substituted%20benzenesulfonamides%20as%20selective%20inhibitors%20of%20carbonic%20anhydrase%20isoforms.pdf?subformat=pdfa$$xpdfa$$yRestricted
000442800 909CO $$ooai:bib-pubdb1.desy.de:442800$$pVDB
000442800 9131_ $$0G:(DE-HGF)POF3-622$$1G:(DE-HGF)POF3-620$$2G:(DE-HGF)POF3-600$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF3-6G3$$aDE-HGF$$bForschungsbereich Materie$$lVon Materie zu Materialien und Leben$$vFacility topic: Research on Matter with Brilliant Light Sources$$x0
000442800 9141_ $$y2020
000442800 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000442800 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000442800 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bEUR J MED CHEM : 2015
000442800 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000442800 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000442800 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000442800 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000442800 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000442800 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000442800 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000442800 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000442800 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000442800 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000442800 9201_ $$0I:(DE-H253)EMBL-User-20120814$$kEMBL-User$$lEMBL-User$$x0
000442800 980__ $$ajournal
000442800 980__ $$aVDB
000442800 980__ $$aI:(DE-H253)EMBL-User-20120814
000442800 980__ $$aUNRESTRICTED